The American Board of Internal Medicine has announced six appointments to its specialty boards, according to a press release.
Board members set standards related to certification and maintenance of certification programs. According to the release, the specialty boards include "at least two nonphysician members, including both a member of the interprofessional health care team and a public member with a patient/caregiver perspective."
“In 2013, ABIM updated its governance structure to recognize that, amid the changing health care landscape, broader perspectives are needed to ensure that board certification continues to affirm that physicians have the clinical judgment, skills and attitudes to deliver excellent patient care,” Richard J. Baron, MD, president and CEO of ABIM, said in the release. “Including patients, caregivers and health care professionals who are not internists as governance members holds ABIM accountable to the profession and to the public.”
Richard J. Baron
As detailed in the release, Michael McDuffie, PhD, associate professor and chair of the philosophy department at California State University was appointed to the critical care medicine board. Jeanne Keruly, CRNP, assistant professor of medicine in the division of infectious diseases, Johns Hopkins School of Medicine and adjunct professor in the School of Nursing at Johns Hopkins University was named to the infections disease board.
Additionally, the nephrology board added both Samir Nangia, MD, vice chair of medicine and member of the leadership committee at Methodist Mansfield Hospital and a physician partner with Dallas Renal Group and Nancy Hewitt Spaeth, RN, member of Patient-Centered Outcomes Research Institute (PCORI) Northwest Renal Network Patient Advisory Committee and National End Stage Renal Disease Learning and Action Network.
Apold, PhD, RN, clinical professor of nursing at New York University College of Nursing was appointed to the internal medicine board. Atulya Deodhar, MD, professor of medicine and medical director of rheumatology clinics at the division of arthritis and rheumatic diseases at Oregon Health & Science University, was appointed to the rheumatology board.